Two phase 3 studies of oral tofacitinib in patients with moderate to severe plaque psoriasis: 16-week efficacy and safety results

被引：0

作者：

Papp, Kim A. ^{[1
]}

Menter, Martin A. ^{[2
]}

Abe, Masatoshi ^{[3
]}

Elewski, Boni E. ^{[4
]}

Feldman, Steven R. ^{[5
]}

Gottlieb, Alice G. ^{[6
]}

Thaci, Diamant ^{[7
]}

Luger, Thomas ^{[8
]}

Tatulych, Svitlana ^{[9
]}

Gupta, Pankaj ^{[9
]}

Proulx, James ^{[9
]}

Lan, Shu-Ping ^{[9
]}

Wolk, Robert ^{[9
]}

机构：

[1] Probity Med Res & K Papp Clin Res Inc, Waterloo, ON, Canada

[2] Baylor Res Inst, Dallas, TX USA

[3] Gunma Univ Hosp, Maebashi, Japan

[4] Univ Alabama, Tuscaloosa, AL 35487 USA

[5] Wake Forest Univ, Winston Salem, NC 27109 USA

[6] Tufts Med Ctr, Boston, MA USA

[7] Univ Hosp Schleswig Holstein, Kiel, Germany

[8] Univ Munster, Dept Dermatol, D-48149 Munster, Germany

[9] Pfizer Inc, Groton, CT 06340 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

2020

引用

页码：AB66 / AB66

页数：1

共 50 条

[31] BIMEKIZUMAB EFFICACY IN MODERATE TO SEVERE PLAQUE PSORIASIS: IMPROVEMENTS IN FATIGUE OBSERVED IN TWO PHASE 3 STUDIES [J].

Gottlieb, Alice B. ;

Augustin, Matthias ;

Lambert, Jo ;

Pinter, Andreas ;

Savage, Laura J. ;

Tsai, Tsen-Fang ;

Foley, Peter ;

Paul, Carle ;

Warham, Rhys ;

Lambert, Jeremy ;

Wiegratz, Susanne ;

Stahle, Mona .

ACTA DERMATO-VENEREOLOGICA, 2024, 104

[32] Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the SustaIMM phase 2/3 trial [J].

Ohtsuki, Mamitaro ;

Fujita, Hideki ;

Watanabe, Mitsunori ;

Suzaki, Keiko ;

Flack, Mary ;

Huang, Xin ;

Kitamura, Susumu ;

Valdes, Joaquin ;

Igarashi, Atsuyuki .

JOURNAL OF DERMATOLOGY, 2019, 46 (08) :686-694

[33] Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials [J].

Sandborn, William ;

Sands, Bruce E. ;

D'Haens, Geert R. ;

Vermeire, Severine ;

Schreiber, Stefan ;

Danese, Silvio ;

Panes, Julian ;

Feagan, Brian G. ;

Reinisch, Walter ;

Niezychowski, Wojciech ;

Friedman, Gary ;

Lawendy, Nervin ;

Yu, Dahong ;

Woodworth, Deborah A. ;

Mukherjee, Arnab ;

Healey, Paul J. ;

Zhang, Haiying ;

Su, Chinyu .

GASTROENTEROLOGY, 2016, 150 (04) :S157-S157

[34] Oral tofacitinib for the treatment of adults with moderate to severe chronic plaque psoriasis [J].

Korman, Abraham M. ;

Hill, Dane ;

Alikhan, Ali ;

Feldman, Steven R. .

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (04) :525-539

[35] Relationships between tildrakizumab dose, exposure, efficacy and safety in phase 3 studies in moderate to severe plaque psoriasis [J].

Strober, Bruce E. ;

Sofen, Howard ;

Yamauchi, Paul S. ;

Mendelsohn, Alan M. ;

Parno, Jeff ;

Lowry, Simon ;

Rozzo, Stephen J. ;

Elewski, Boni E. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) :AB117-AB117

[36] Early clinical response as a predictor of subsequent response to tofacitinib treatment: Results from two phase 3 studies of subjects with moderate to severe plaque psoriasis [J].

Tan, Huaming ;

Valdez, Hernan ;

Wolk, Robert ;

Tallman, Anna ;

Gordon, Kenneth B. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) :AB244-AB244

[37] A 12-week phase 3 study of efficacy and safety of etanercept therapy in children and adolescents with moderate to severe plaque psoriasis [J].

Paller, Amy ;

Siegfried, Elaine ;

Langley, Richard ;

Gottlieb, Alice .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) :AB195-AB195

[38] Safety of oral tazarotene in moderate to severe plaque psoriasis [J].

Walker, PS ;

Gottlieb, A ;

Guenther, L ;

Menter, A .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) :P153-P153

[39] Efficacy and safety of a novel formulation of an oral fumarate, BG-12, in patients with moderate to severe plaque psoriasis: Results of a phase III study [J].

Mrowietz, U ;

Spellman, MC .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) :P182-P182

[40] Efficacy and safety of etanercept in moderate to severe plaque psoriasis [J].

Tunca, M. ;

Koc, E. ;

Akar, A. ;

Kurumlu, Z. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 :53-53

← 1 2 3 4 5 →